Syngene International Limited

Price Chart

Risk-Adjusted Performance

Syngene International Limited (SYNGENE) Price Performance

Syngene International Limited (SYNGENE) trades on NSE in INR. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at INR398.85, down 3.83% from the previous close.

Over the past year, SYNGENE has traded between a low of INR398.65 and a high of INR683.05. The stock has lost 40.8% over this period. It is currently 41.6% below its 52-week high.

Syngene International Limited has a market capitalization of $162.42B, with a price-to-earnings ratio of 46.29.

About Syngene International Limited

Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals; and chemical, formulation, analytical, and clinical development services. It provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical studies, biometrics and clinical data management, central lab, regulatory, medical monitoring, pharmacovigilance, and medical writing services. In addition, the company offers chemistry, biology, safety assessment, computational, and data sciences for traditional small molecule therapeutics; biologics; and specialty modalities, such as peptides, oligonucleotides, antibody-drug conjugates, and targeted degradation/stabilization. It serves pharmaceutical, biotechnology, animal health, nutrition, consumer goods, agrochemical, performance and specialty materials, and other companies. The company has collaborations with Bristol-Myers Squibb, Baxter Inc., and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.